Enhanced production of exopolysaccharide matrix and biofilm by a menadione-auxotrophic Staphylococcus aureus small-colony variant

Journal of Medical Microbiology
Rachna SinghMeera Sharma

Abstract

The role of Staphylococcus aureus small-colony variants (SCVs) in the pathogenesis of biofilm-associated infections remains unclear. This study investigated the mechanism behind increased biofilm-forming potential of a menadione-auxotrophic Staphylococcus aureus SCV compared with the wild-type parental strain, as recently reported by our laboratory. SCVs displayed an autoaggregative phenotype, with a greater amount of polysaccharide intercellular adhesin (PIA), significantly reduced tricarboxylic acid cycle activity and a decreased susceptibility to aminoglycosides and cell-wall inhibitors compared with wild-type. The biofilms formed by the SCV were highly structured, consisting of large microcolonies separated by channels, and contained more biomass as well as significantly more PIA than wild-type biofilms. The surface hydrophobicity of the two phenotypes was similar. Thus, the autoaggregation and increased biofilm-forming capacity of menadione-auxotrophic Staphylococcus aureus SCVs in this study was related to the enhanced production of PIA in these variants.

References

Aug 1, 1978·Journal of Clinical Microbiology·J F AcarP Lagrange
Jan 1, 1995·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·R A ProctorR D Arbeit
Dec 24, 1997·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·C von EiffG Peters
Jan 22, 1998·Applied and Environmental Microbiology·P F PérezG L De Antoni
Aug 26, 1998·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·R A ProctorG Peters
Oct 14, 1998·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·R A Proctor, G Peters
May 21, 1999·Science·J W CostertonE P Greenberg
Apr 5, 2003·Journal of Medical Microbiology·Susanne HäusslerIvo Steinmetz
Jul 15, 2004·FEMS Microbiology Letters·Kimberly K Jefferson
Jan 11, 2005·Trends in Microbiology·C A FuxP Stoodley
Aug 9, 2005·Applied and Environmental Microbiology·Mary Jo KirisitsMatthew R Parsek
Jan 27, 2006·Journal of Orthopaedic Science : Official Journal of the Japanese Orthopaedic Association·Seisuke NishimuraHiroyuki Shindo
Mar 17, 2006·Nature Reviews. Microbiology·Richard A ProctorGeorg Peters
Nov 17, 2006·Journal of Clinical Microbiology·Silke BesierThomas A Wichelhaus
Dec 26, 2006·Journal of Bacteriology·Magee Allegrucci, Karin Sauer
Apr 3, 2007·Letters in Applied Microbiology·P S StewartB Pitts
May 6, 2008·Current Topics in Microbiology and Immunology·M Otto
Aug 5, 2008·Journal of Bacteriology·Christian KohlerSusanne Engelmann

❮ Previous
Next ❯

Citations

Mar 15, 2013·The Journal of Antimicrobial Chemotherapy·Laetitia G GarciaFrançoise Van Bambeke
Mar 2, 2011·Antimicrobial Agents and Chemotherapy·Gabriel MitchellFrançois Malouin
Mar 21, 2012·Antimicrobial Agents and Chemotherapy·Joe LatimerAndrew J McBain
Jun 25, 2014·Future Microbiology·Rachna Singh, Pallab Ray
Jul 19, 2012·Journal of Peptide Science : an Official Publication of the European Peptide Society·Leonardo BaldassarreIvana Cacciatore
Jun 4, 2011·Microbiology·Rachna SinghArunaloke Chakrabarti
Sep 9, 2015·Frontiers in Microbiology·Efstathios GiaourisManuel Simões
Jun 1, 2013·Infection, Genetics and Evolution : Journal of Molecular Epidemiology and Evolutionary Genetics in Infectious Diseases·Barbara C Kahl
Apr 4, 2017·FEMS Microbiology Reviews·Clayton W Hall, Thien-Fah Mah
Oct 9, 2015·Microbiology Insights·Benjamin E JohnsSarah E Maddocks
Mar 27, 2019·Physical Biology·Vernita GordonKristin Kovach
Dec 26, 2018·Journal of Dairy Science·Julie Côté-Gravel, François Malouin
Aug 1, 2020·Frontiers in Cellular and Infection Microbiology·Derry K MercerAlfredo M Angeles-Boza
Feb 13, 2021·Antibiotics·Christian KranjecDzung B Diep
Apr 7, 2021·Antimicrobial Agents and Chemotherapy·Sadaf SoltaniVahid Soheili

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Aminoglycosides (ASM)

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Biofilm & Infectious Disease

Biofilm formation is a key virulence factor for a wide range of microorganisms that cause chronic infections.Here is the latest research on biofilm and infectious diseases.

Aminoglycosides

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Biofilms

Biofilms are adherent bacterial communities embedded in a polymer matrix and can cause persistent human infections that are highly resistant to antibiotics. Discover the latest research on Biofilms here.

Related Papers

British Journal of Biomedical Science
W J Looney
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases
S YagciB Sener
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
Daniel J WolterLucas R Hoffman
© 2021 Meta ULC. All rights reserved